Tanapox: a new disease caused by a pox virus.
Downie AW, Taylor-Robinson CH, Caunt AE, Nelson GS, Manson-Bahr PE, Matthews TC.
Br Med J. 1971 Feb 13;1(5745):363-8. doi: 10.1136/bmj.1.5745.363.
Comparison of Tanapox virus and Yaba-like viruses causing epidemic disease in monkeys.
Downie AW, España C.
J Hyg (Lond). 1972 Mar;70(1):23-32. doi: 10.1017/s0022172400022051.
Tanapox virus infection.
Croitoru AG, Birge MB, Rudikoff D, Tan MH, Phelps RG.
Skinmed. 2002 Nov-Dec;1(2):156-7. doi: 10.1111/j.1540-9740.2002.01778.x.
Studies on Tanapox virus.
Knight JC, Novembre FJ, Brown DR, Goldsmith CS, Esposito JJ.
Virology. 1989 Sep;172(1):116-24. doi: 10.1016/0042-6822(89)90113-x.
Real-time PCR assay for the detection of tanapox virus and yaba-like disease virus.
Zimmermann P, Thordsen I, Frangoulidis D, Meyer H.
J Virol Methods. 2005 Dec;130(1-2):149-53. doi: 10.1016/j.jviromet.2005.06.015. Epub 2005 Jul 28.
Poxvirus-driven human diseases and emerging therapeutics.
Srinivasan Rajsri K, Rao M.
Ther Adv Infect Dis. 2022 Nov 14;9:20499361221136751. doi: 10.1177/20499361221136751. eCollection 2022 Jan-Dec.
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.
Wang H, Borlongan M, Hemminki A, Basnet S, Sah N, Kaufman HL, Rabkin SD, Saha D.
Hum Gene Ther. 2023 Sep;34(17-18):878-895. doi: 10.1089/hum.2023.099.
Estimating the geographic distribution of human Tanapox and potential reservoirs using ecological niche modeling.
Monroe BP, Nakazawa YJ, Reynolds MG, Carroll DS.
Int J Health Geogr. 2014 Sep 25;13:34. doi: 10.1186/1476-072X-13-34.
Tropism of Tanapox virus infection in primary human cells.
Nazarian SH, Barrett JW, Stanford MM, Johnston JB, Essani K, McFadden G.
Virology. 2007 Nov 10;368(1):32-40. doi: 10.1016/j.virol.2007.06.019. Epub 2007 Jul 16.
Tanapoxvirus: From discovery towards oncolytic immunovirotherapy.
Suryawanshi YR, Zhang T, Razi F, Essani K.
J Cancer Res Ther. 2020 Jul-Sep;16(4):708-712. doi: 10.4103/jcrt.JCRT_157_18.
